| Severity | Timing | Rationale |
|---|---|---|
| Mild pancreatitis | Same admission (ideally within 72h) | Delaying to outpatient → 25–30% recurrence rate. PONCHO, 2015 showed same-admission chole is safe and reduces recurrence. |
| Severe/necrotizing | Delay 4–6 weeks | Operating during severe pancreatitis = higher complication rate. Wait for inflammation to resolve. |
| Test | Purpose / Key Values |
|---|---|
| Lipase | > 3× ULN diagnostic. Don't need to normalize before feeding/surgery. |
| ALT | > 150 U/L = ~85% PPV for gallstone etiology -very helpful! |
| Total/direct bilirubin | Elevated = stone may still be impacted. Improving = stone likely passed. |
| Alk phos | Elevated in biliary obstruction |
| CBC | Leukocytosis (inflammation), hemoconcentration (dehydration) |
| BMP | Cr (organ failure), glucose, calcium |
| CRP at 48h | Severity marker. CRP > 150 at 48h suggests severe pancreatitis. |
| RUQ ultrasound | Gallstones, CBD dilation (> 6 mm suggests obstruction) |
| MRCP | If diagnostic uncertainty -avoids invasive ERCP. Better for CBD stone detection. |
| CT abdomen/pelvis | Only if not improving by day 3–5 (assess for necrosis, complications) |
| Drug | Dose | Notes |
|---|---|---|
| Lactated Ringer's | Goal-directed (not aggressive) | WATERFALL 2022: aggressive fluids ↑ overload, no benefit |
| Hydromorphone (Dilaudid) | 0.5–1 mg IV q3–4h PRN | Pain control. Morphine is also acceptable. |
| Ondansetron (Zofran) | 4 mg IV q6h PRN | Nausea/vomiting |
| NO prophylactic antibiotics | - | Antibiotics only if infected necrosis or cholangitis confirmed |
Patient: 48F with sudden epigastric pain radiating to back after fatty meal. Lipase 3200, ALT 280, T. bili 2.8, CBD 7 mm on RUQ US with gallstones. HR 92, BP 128/78. No fever.
Key findings: Gallstone pancreatitis (ALT > 150 = ~85% PPV for gallstone etiology). No cholangitis (afebrile, no Charcot triad). Mild disease, no organ failure.
Management:
Teaching point: Old teaching: NPO until pain-free and lipase normalizes. New evidence: early oral feeding is safe and reduces LOS. Don't delay feeding waiting for lab improvement.
Patient: 55M heavy drinker. Lipase 8400, Cr 2.1, lactate 3.8, HR 118, BP 88/52. CT (72h): > 50% pancreatic necrosis with peripancreatic fluid collections. CRP 340 at 48h.
Key findings: Severe pancreatitis (organ failure + necrosis). BISAP ≥ 3. Alcoholic etiology. High risk for infected necrosis (30-40% of necrotizing pancreatitis).
Management:
Teaching point: The step-up approach (drain → endoscopic/minimally invasive necrosectomy → open surgery) has replaced open necrosectomy as standard of care. ~35% of patients improve with drainage alone.
Patient: 62F with epigastric pain, lipase 1800, T. bili 6.4 (rising), fever 39.1°C, rigors. WBC 18K. RUQ US: CBD 12 mm, gallstones, no intrahepatic dilation.
Key findings: Charcot triad (fever + jaundice + RUQ pain) = cholangitis. This is the one indication for urgent ERCP in gallstone pancreatitis. Rising bilirubin with fever = impacted stone with biliary sepsis.
Management:
Teaching point: Cholangitis is the ONLY absolute indication for ERCP in gallstone pancreatitis. Without cholangitis, most stones pass spontaneously and ERCP adds risk without benefit.
| Parameter | Frequency | Target / Action |
|---|---|---|
| Lipase | Trending (not daily) | Don't need to normalize before feeding or surgery |
| LFTs (bilirubin, ALT) | Daily | Improving bilirubin = stone likely passed. Persistently elevated → ERCP. |
| BMP | Daily | Cr (organ failure), calcium (severity marker) |
| CRP at 48h | Once at 48h | > 150 = likely severe pancreatitis |
| CT abdomen | Only if not improving day 3–5 | Assess for necrosis, pseudocyst, fluid collections |
| Surgical consult | Early (same admission) | Cholecystectomy timing -don't discharge without a plan |